Fiduciary Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.8M Sell
59,411
-759
-1% -$364K 0.32% 51
2026
Q1
$29.6M Sell
60,170
-3,715
-6% -$2.02M 0.35% 49
2025
Q4
$37M Sell
63,885
-298
-0.5% -$169K 0.42% 42
2025
Q3
$31.1M Buy
64,183
+215
+0.3% +$100K 0.35% 49
2025
Q2
$25.9M Sell
63,968
-2,258
-3% -$944K 0.32% 52
2025
Q1
$33M Sell
66,226
-86
-0.1% -$46.6K 0.43% 41
2024
Q4
$34.5M Sell
66,312
-356
-0.5% -$196K 0.46% 42
2024
Q3
$41.2M Buy
66,668
+196
+0.3% +$116K 0.58% 34
2024
Q2
$36.8M Sell
66,472
-136
-0.2% -$77.9K 0.55% 35
2024
Q1
$38.7M Sell
66,608
-1,201
-2% -$674K 0.59% 33
2023
Q4
$36M Sell
67,809
-4,726
-7% -$2.29M 0.6% 31
2023
Q3
$36.7M Sell
72,535
-1,068
-1% -$569K 0.67% 29
2023
Q2
$38.4M Buy
73,603
+1,801
+3% +$972K 0.68% 28
2023
Q1
$41.4M Sell
71,802
-1,451
-2% -$818K 0.77% 24
2022
Q4
$40.3M Sell
73,253
-360
-0.5% -$191K 0.78% 22
2022
Q3
$37.3M Sell
73,613
-287
-0.4% -$161K 0.81% 22
2022
Q2
$40.1M Sell
73,900
-2,034
-3% -$1.12M 0.85% 21
2022
Q1
$44.9M Sell
75,934
-2,509
-3% -$1.44M 0.8% 22
2021
Q4
$52.3M Sell
78,443
-1,270
-2% -$793K 0.86% 20
2021
Q3
$45.5M Sell
79,713
-621
-0.8% -$341K 0.81% 21
2021
Q2
$40.5M Sell
80,334
-2,519
-3% -$1.19M 0.78% 22
2021
Q1
$37.8M Sell
82,853
-1,203
-1% -$574K 0.77% 24
2020
Q4
$39.2M Sell
84,056
-2,449
-3% -$1.15M 0.82% 21
2020
Q3
$38.2M Sell
86,505
-2,107
-2% -$870K 0.9% 20
2020
Q2
$32.1M Sell
88,612
-2,644
-3% -$886K 0.79% 25
2020
Q1
$25.9M Sell
91,256
-377
-0.4% -$119K 0.75% 28
2019
Q4
$29.8M Sell
91,633
-875
-0.9% -$265K 0.69% 32
2019
Q3
$26.9M Buy
92,508
+3,648
+4% +$1.04M 0.68% 35
2019
Q2
$26.1M Buy
88,860
+888
+1% +$245K 0.68% 34
2019
Q1
$24.1M Buy
87,972
+450
+0.5% +$112K 0.65% 38
2018
Q4
$19.6M Sell
87,522
-2,162
-2% -$507K 0.6% 44
2018
Q3
$21.9M Sell
89,684
-1,143
-1% -$263K 0.61% 41
2018
Q2
$18.8M Sell
90,827
-3,285
-3% -$697K 0.57% 48
2018
Q1
$19.4M Sell
94,112
-2,271
-2% -$477K 0.6% 48
2017
Q4
$18.3M Sell
96,383
-8,094
-8% -$1.55M 0.54% 53
2017
Q3
$19.8M Sell
104,477
-5,340
-5% -$967K 0.61% 52
2017
Q2
$19.2M Sell
109,817
-6,484
-6% -$1.09M 0.59% 47
2017
Q1
$17.9M Sell
116,301
-7,802
-6% -$1.19M 0.55% 53
2016
Q4
$17.5M Sell
124,103
-8,587
-6% -$1.27M 0.57% 52
2016
Q3
$21.1M Sell
132,690
-2,971
-2% -$458K 0.72% 37
2016
Q2
$20M Sell
135,661
-4,222
-3% -$623K 0.7% 39
2016
Q1
$19.8M Buy
139,883
+8,585
+7% +$1.15M 0.7% 39
2015
Q4
$18.6M Sell
131,298
-5,277
-4% -$704K 0.79% 39
2015
Q3
$16.7M Sell
136,575
-122
-0.1% -$15.9K 0.75% 45
2015
Q2
$17.7M Sell
136,697
-4,020
-3% -$524K 0.74% 44
2015
Q1
$18.9M Sell
140,717
-1,935
-1% -$249K 0.78% 42
2014
Q4
$17.9M Buy
142,652
+6,909
+5% +$840K 0.75% 45
2014
Q3
$16.5M Sell
135,743
-412
-0.3% -$50.1K 0.73% 44
2014
Q2
$16.1M Sell
136,155
-273
-0.2% -$32.1K 0.69% 51
2014
Q1
$16.4M Sell
136,428
-1,642
-1% -$195K 0.73% 48
2013
Q4
$15.4M Sell
138,070
-4,074
-3% -$405K 0.68% 50
2013
Q3
$13.1M Sell
142,144
-2,970
-2% -$269K 0.6% 57
2013
Q2
$12.3M Buy
+145,114
New +$12.1M 0.57% 59

Other funds holding TMO

Fiduciary Trust's TMO Position: Q2 2026 in Review

Fiduciary Trust reduced its Thermo Fisher Scientific (TMO) stake by 1.3% in Q2 2026, selling an estimated $364K and leaving 59,411 shares worth $29.8M. The position accounts for 0.32% of the portfolio, ranked #51.

Fiduciary Trust first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $52.3M in Q4 2021. 2,604 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Fiduciary Trust held 59,411 shares of Thermo Fisher Scientific worth $29.8M as of Q2 2026.
  • Fiduciary Trust sold 759 Thermo Fisher Scientific shares in Q2 2026, an estimated $364K.
  • Thermo Fisher Scientific made up 0.32% of Fiduciary Trust's portfolio in Q2 2026, its #51 holding.
  • Fiduciary Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Fiduciary Trust's Thermo Fisher Scientific position peaked at $52.3M in Q4 2021.
  • 2,604 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.